Skip to main content
OpenTrials

Clinical trial condition

Demyelinating Diseases

Explore clinical trials studying Demyelinating Diseases. Study availability and eligibility vary by location and protocol.

2,934 public trials 459 recruiting studies
Refine in advanced search Browse all conditions

Demyelinating Diseases trial results

Completed

Safety and Tolerability of Conversion From Oral, Injectable, or Infusion Disease Modifying Therapies to Dose-titrated Oral Siponimod (Mayzent) in Advancing RMS Patients

NCT03623243

Conditions
Advancing Multiple Sclerosis, Autoimmune Diseases, Autoimmune Diseases of the Nervous System, +6 more
Locations
  • Novartis Investigative Site Birmingham, Alabama, United States
  • Novartis Investigative Site Cullman, Alabama, United States
  • Alabama Neurology Associates Homewood, Alabama, United States
  • Novartis Investigative Site Tucson, Arizona, United States
View all 55 locations
View Trial Details
Completed

Exploring the Immune Response to SARS-CoV-2 modRNA Vaccines in Patients With Secondary Progressive Multiple Sclerosis (AMA-VACC)

NCT04792567

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, COVID-19, +22 more
Locations
  • Novartis Investigative Site Mittweida, Saxony, Germany
  • Novartis Investigative Site Bogen, Germany
  • Novartis Investigative Site Chemnitz, Germany
  • Novartis Investigative Site Dresden, Germany
View Trial Details

Related conditions